Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

611
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
611

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of nitric oxide synthase gene polymorphism on inflammatory response in patients with chronic obstructive pulmonary disease.

Cytokine·2023
Same author

Validation of hemodynamic stress calculation in coronary computed tomography angiography versus intravascular ultrasound.

Quantitative imaging in medicine and surgery·2023
Same author

Improved characterization of lenticulostriate arteries using compressed sensing time-of-flight at 7T.

European radiology·2023
Same author

Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial.

International journal of stroke : official journal of the International Stroke Society·2023
Same author

Adherence to a healthy lifestyle and brain structural imaging markers.

European journal of epidemiology·2023
Same author

Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study.

Stroke and vascular neurology·2023

Related Experiment Video

Updated: Aug 9, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Artificial Intelligence-Assisted Transcriptomic Analysis to Advance Cancer Immunotherapy.

Yu Gui1,2, Xiujing He1, Jing Yu1

  • 1Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China.

Journal of Clinical Medicine
|February 25, 2023
PubMed
Summary

Artificial intelligence (AI) enhances cancer immunotherapy by analyzing transcriptomics data. AI-assisted analysis improves understanding of tumor heterogeneity, microenvironment, and adverse events, paving the way for better cancer treatments.

Keywords:
artificial intelligencedrug resistancedrug target discoveryimmune-related adverse eventsimmunotherapytranscriptomic analysistumor microenvironment

More Related Videos

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

317
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K

Related Experiment Videos

Last Updated: Aug 9, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

317
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K

Area of Science:

  • Cancer Research
  • Immunotherapy
  • Genomics
  • Artificial Intelligence

Background:

  • Immunotherapy has revolutionized cancer treatment but faces challenges like low response rates and adverse events.
  • Transcriptomics, especially single-cell RNA sequencing (scRNA-seq), offers insights into treatment response and toxicity.
  • Artificial intelligence (AI) is crucial for efficient analysis of complex transcriptomic data in cancer research.

Purpose of the Study:

  • To review emerging AI-assisted transcriptomic technologies for cancer research.
  • To highlight advancements in understanding cancer immunotherapy using AI-driven transcriptomic analysis.
  • To provide insights into tumor heterogeneity, microenvironment, and immunotherapy challenges.

Main Methods:

  • Review of current literature on AI-assisted transcriptomic technologies.
  • Analysis of scRNA-seq data applications in cancer immunotherapy.
  • Focus on AI's role in deciphering molecular mechanisms of immunotherapy response and toxicity.

Main Results:

  • AI significantly improves the analysis of transcriptomic data for cancer immunotherapy.
  • AI-assisted transcriptomics provides deeper insights into tumor heterogeneity and the tumor microenvironment.
  • AI aids in understanding drug resistance, immune-related adverse events, and identifying new therapeutic targets.

Conclusions:

  • AI-assisted transcriptomic analysis is a powerful tool for advancing cancer immunotherapy.
  • This approach offers solutions to overcome current limitations in immunotherapy efficacy and safety.
  • The review provides evidence to support the integration of AI in future cancer immunotherapy research and development.